Zobrazeno 1 - 10
of 38
pro vyhledávání: '"E. Ruffino"'
Autor:
Yasmeen M. Byrnes, MD, Gabriel Makar, MD, Joshua D. Madera, MS, Amanda E. Ruffino, BA, Katie Frank, MS, Thomas R. Bowen, MD, Sean M. Devitt, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss 7, p e5971 (2024)
Summary:. Orthoplastic surgery is a multidisciplinary approach that is well-studied for extremity trauma, but not for musculoskeletal oncologic reconstruction. Here, the authors describe the application of a collaborative orthoplastic approach for th
Externí odkaz:
https://doaj.org/article/1870931f85e041c0981cec4652cf332b
Autor:
Joshua D. Madera, Amanda E. Ruffino, Adriana Feliz, Kenneth L. McCall, Corey S. Davis, Brian J. Piper
Publikováno v:
Pharmacy, Vol 12, Iss 1, p 14 (2024)
The United States (US) opioid epidemic is a persistent and pervasive public health emergency that claims the lives of over 80,000 Americans per year as of 2021. There have been sustained efforts to reverse this crisis over the past decade, including
Externí odkaz:
https://doaj.org/article/06d6efc4fbe4474f8d5d1ab758fd0e1e
Autor:
R Rossini, F Angelini, F Giordana, L Coppini, I Ferraro, E Ruffino, F Varbella, E Tizzani, G Coletta, G Musumeci
Publikováno v:
European Heart Journal Supplements. 25:D71-D72
Background To determine the safety and feasibility of in–hospital sacubitril/valsartan initiation after clinical stabilization in patients with acute decompensated heart failure (ADHF) and reduced ejection fraction (EF). Methods This retrospective,
Autor:
Joshua D. Madera, Amanda E. Ruffino, Adriana Feliz, Kenneth L. McCall, Corey S. Davis, Brian J. Piper
The United States (US) opioid epidemic is a persistent and pervasive public health emergency that now claims the lives of over 100,000 Americans per year. There have been sustained efforts to reverse this crisis over the past decade, including a numb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::577ab4229c26763cc68d2f31b9a7dfef
https://doi.org/10.21203/rs.3.rs-2365273/v1
https://doi.org/10.21203/rs.3.rs-2365273/v1
Autor:
E Ruffino, L Coppini, I Ferraro, F Giordana, G Coletta, P Desalvo, I Baralis, A Talenti, R Rossini
Publikováno v:
European Heart Journal Supplements. 25:D74-D74
Introduction Acute myocarditis is an important cause of chest pain in the young, with potential acute arrhythmic and hemodynamic complications and possible evolution into chronic inflammatory cardiomyopathy. Even though multiple triggers can be recog
Autor:
Joshua D. Madera, Amanda E. Ruffino, Adriana Feliz, Kenneth L. McCall, Corey S. Davis, Brian J. Piper
BackgroundThe United States (US) opioid epidemic is a persistent and pervasive public health emergency that now claims the lives of over 100,000 Americans per year. There have been sustained efforts to reverse this crisis over the past decade, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1843e89088882a12d9903dd1f025520b
https://doi.org/10.1101/2021.12.02.21266660
https://doi.org/10.1101/2021.12.02.21266660
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Chimeric antigen receptor (CAR) T cell therapy is being studied for the treatment of haematologic malignancies. CARs are synthetic receptors that reveal the specificity, purpose and metabolism of T cells. The first step in m
Autor:
Camilla Torlasco, Giuseppina Quattrocchi, James C. Moon, Paola Sormani, Maria Domenica Cappellini, Patrizia Pedrotti, Angela Milazzo, Cristina Giannattasio, A Abdel-Gadir, E. Ruffino, Elena Cassinerio, C. Mollica, Gianfranco Parati
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 20
Autor:
G Laganà, C Di Mauro, G. Saibene, B Re, E Ruffino, M Galassi, R. Langella, V Ladisa, C Della Costanza, G. Antonacci
Publikováno v:
Eur J Hosp Pharm
Background The oncolytic virus (OV) Talimogene Laherparepvec (T-VEC) is a microorganism genetically modified (MOGM), since it is genetically engineered to no longer be capable of causing infection or of spreading in normal cells. Even if it was consi
Publikováno v:
Patient safety and risk management.
Background Ifosfamide is an alkylating agent effective in young patients affected by sarcoma. Its use is limited due to severe side effects: haemorrhagic cystitis, prevented with mesna; neurotoxicity is currently its worse adverse effect. Hepatic con